You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Peginterferon lambda

Showing 1 - 25 of 455
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis Delta Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (Peginterferon

Not yet recruiting
  • Chronic Hepatitis Delta
  • Peginterferon Lambda
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jul 25, 2023

Sars-CoV-2 Infection Trial in Baltimore (Peginterferon lambda alfa-1a subcutaneous injection, Saline)

Terminated
Has Results
  • Sars-CoV-2 Infection
  • Peginterferon lambda alfa-1a subcutaneous injection
  • Saline
  • Baltimore, Maryland
    Johns Hopkins Hospital
Jul 12, 2022

Sars-CoV2, Covid19 Trial in Toronto (Peginterferon Lambda-1A, Placebo)

Active, not recruiting
  • Sars-CoV2
  • Covid19
  • Peginterferon Lambda-1A
  • Placebo
  • Toronto, Ontario, Canada
    Toronto General Hospital
Apr 4, 2022

COVID-19 Trial in Stanford (Peginterferon Lambda-1a, Placebo)

Completed
Has Results
  • COVID-19
  • Peginterferon Lambda-1a
  • Placebo
  • Stanford, California
    Stanford University School of Medicine
Nov 24, 2021

Hepatitis D, Chronic Trial in Israel, New Zealand, Pakistan (Peginterferon Lambda-1A)

Completed
Has Results
  • Hepatitis D, Chronic
  • Peginterferon Lambda-1A
  • Beersheba, Israel
  • +3 more
Dec 20, 2022

Sars-CoV2, Covid-19 Trial in Brazil, Canada (Peginterferon Lambda-1A, )

Recruiting
  • Sars-CoV2
  • Covid-19
  • Peginterferon Lambda-1A
  • placebo
  • Botucatu, Brazil
  • +6 more
Jan 17, 2022

Hepatitis Delta Virus Trial in Worldwide (Peginterferon Lambda-1a)

Recruiting
  • Hepatitis Delta Virus
  • Peginterferon Lambda-1a
  • Los Angeles, California
  • +61 more
Jan 30, 2023

Covid19, SARS-Associated Coronavirus Trial in Brazil (Fluvoxamine Maleate 100 MG [Luvox], Budesonide Powder, Placebo (mild

Recruiting
  • Covid19
  • SARS-Associated Coronavirus
  • Fluvoxamine Maleate 100 MG [Luvox]
  • +4 more
  • Betim, MG, Brazil
  • +11 more
Jul 3, 2022

Liver Disease, Hepatitis D Trial run by the NIDDK (Peg-interferon lambda, Lonafarnib, Ritonavir)

Completed
Has Results
  • Liver Disease
  • Hepatitis D
  • Peg-interferon lambda
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 6, 2021

Hepatitis C Virus Trial in Worldwide (Pegylated-Interferon-lambda, Ribavirin, Daclatasvir)

Completed
Has Results
  • Hepatitis C Virus
  • Pegylated-Interferon-lambda
  • +2 more
  • Palo Alto, California
  • +31 more
Aug 7, 2020

Hepatitis C Virus Trial in Worldwide (Peginterferon Lambda-1a, Peginterferon Alfa-2a, Ribavirin)

Completed
Has Results
  • Hepatitis C Virus
  • Peginterferon Lambda-1a
  • +3 more
  • Birmingham, Alabama
  • +103 more
Jul 29, 2019

COVID-19, COVID Trial in Boston (Pegylated interferon lambda)

Terminated
Has Results
  • COVID-19
  • COVID
  • Pegylated interferon lambda
  • Boston, Massachusetts
    Massachusetts General Hospital
Jun 29, 2022

Study of the Angle Lambda and Ocular Dominance

Recruiting
  • No Eye Disorder
  • Eye examination
  • Paris, France
    Hôpital Necker-Enfants Malades
Jan 16, 2023

Multiple Sclerosis, Relapsing-Remitting Trial in Worldwide (Dimethyl Fumarate, Peginterferon Beta-1a, Placebo)

Terminated
  • Multiple Sclerosis, Relapsing-Remitting
  • Dimethyl Fumarate
  • +2 more
  • Raleigh, North Carolina
  • +22 more
Nov 30, 2022

MRD Detection by NGS in Pediatric B-ALL

Completed
  • Acute Lymphoblastic Leukemia, Pediatric, Next Generation Sequencing
  • MRD
  • Hangzhou, Zhejiang, China
    The Children's Hospital of Zhejiang University School of Medicin
Jul 25, 2023

COVID-19 Trial in Be'er Sheva (Lambda 180 mcg S.C)

Recruiting
  • COVID-19
  • Lambda 180 mcg S.C
  • Be'er Sheva, Israel
    Soroka UMC
Jan 27, 2022

s of Kappa and Lambda Free Light Chains in Central Nervous

Completed
  • Central Nervous System Diseases
  • Multiple Sclerosis
  • Biological collection
  • Clermont-Ferrand, France
  • +13 more
Nov 8, 2021

Lung Transplant Rejection Trial (Prospera)

Not yet recruiting
  • Lung Transplant Rejection
  • Prospera
  • (no location specified)
Jan 3, 2022

Chronic Hepatitis B Trial run by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (VIR-2218 and

Not yet recruiting
  • Chronic Hepatitis B
  • VIR-2218 and peginterferon alfa-2a
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Oct 27, 2023

Protease Inhibitors in Chronic Hepatitis C

Completed
  • Chronic Hepatitis C
    • Graz, Austria
      Department of Internal Medicine, Medical University of Graz
    Jan 11, 2023

    Herpes Zoster Trial (Peginterferon a1b, Peginterferon a1b with valacyclovir, Valacyclovir)

    Not yet recruiting
    • Herpes Zoster
    • Peginterferon α1b
    • +2 more
    • (no location specified)
    Aug 5, 2022

    Hepatitis C, Chronic Trial in United States (ISIS 14803, peginterferon alfa, ribavirin)

    Completed
    • Hepatitis C, Chronic
    • ISIS 14803, peginterferon alfa, ribavirin
    • Birmingham, Alabama
    • +24 more
    Dec 1, 2022

    Chronic Hepatitis B Trial (PEG IFN a-2b; TAF)

    Not yet recruiting
    • Chronic Hepatitis B
    • PEG IFN α-2b; TAF
    • (no location specified)
    Aug 5, 2022

    Chronic Hepatitis B Trial run by the NIDDK (hepatitis B immune globulin (HBIg), Pegylated interferon alfa (pegIFN))

    Withdrawn
    • Chronic Hepatitis B
    • hepatitis B immune globulin (HBIg)
    • Pegylated interferon alfa (pegIFN)
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Apr 4, 2022

    Chronic Hepatitis B Patients With a Normal ALT Level and Low Viremia Trial in Fuzhou (Peginterferon alpha-2b, Nucleotide Analog,

    Recruiting
    • Chronic Hepatitis B Patients With a Normal ALT Level and Low Viremia
    • Peginterferon alpha-2b
    • +2 more
    • Fuzhou, Fujian, China
      Fuzhou General Hospital, Xiamen Univ
    Jan 21, 2022